Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
J.C.Wendl
Phase 2 data in patients with type 2 diabetes demonstrated HbA1c reductions of up to 2.16% at the 12mg dose after 36 weeks, along with 16.9% body weight reduction
Tuttle, H
doi: 10.1001/jamanetworkopen.2022.31982
Ethical approval The study was approved by the Institutional Review Board for Clinical Research Committee (IRB) of Mansoura University with the approval code R.22.10.1897.R1 and with the IRB committee, Al Yousif Hospital, Alkhobar, Saudi Arabia, (AYH IRB: 02/03/2023)
US$ 24.21
US$ 21.23
US$ 21.89
US$ 21.51
US$ 24.80
